New Vaccines for Chronic Respiratory Patients

Chronic respiratory diseases (CRD) are responsible for more than four million deaths worldwide and have become especially prevalent in developed countries. Although the current therapies help manage daily symptoms and improve patients’ quality of life, there is a major need to prevent exacerbations...

Full description

Saved in:
Bibliographic Details
Published inArchivos de bronconeumología (English ed.) Vol. 60; no. 9; pp. 565 - 575
Main Authors Mallah, Narmeen, Urbieta, Ana Dacosta, Rivero-Calle, Irene, Gonzalez-Barcala, Francisco-Javier, Bigoni, Tommaso, Papi, Alberto, Martinón-Torres, Federico
Format Journal Article
LanguageEnglish
Spanish
Published Spain Elsevier España, S.L.U 01.09.2024
Subjects
Chronic Disease
Chronic respiratory diseases
COVID-19 Vaccines
Humans
Influenza
Influenza Vaccines
Monoclonal antibody
Pertussis
Pertussis Vaccine - therapeutic use
Pneumococcal disease vaccine
Pneumococcal Vaccines
Pulmonary Disease, Chronic Obstructive
Respiratory syncytial virus
Respiratory Tract Infections - prevention & control
SARS-CoV-2
Vaccination
Vaccine
Pertussis
SARS-CoV-2
Respiratory syncytial virus
Influenza
Vaccine
Monoclonal antibody
Chronic respiratory diseases
Pneumococcal disease vaccine
Online AccessGet full text

Cover

More Information
Summary:Chronic respiratory diseases (CRD) are responsible for more than four million deaths worldwide and have become especially prevalent in developed countries. Although the current therapies help manage daily symptoms and improve patients’ quality of life, there is a major need to prevent exacerbations triggered mainly by respiratory infections. Therefore, CRD patients are a prime target for vaccination against infectious agents. In the present manuscript we review the state of the art of available vaccines specifically indicated in patients with CRDs. In addition to pneumococcus, influenza, pertussis, and SARS-CoV-2 vaccines, recently added immunization options like vaccines and monoclonal antibodies against respiratory syncytial virus, are particularly interesting in CRD patients. As new products reach the market, health authorities must be agile in updating immunization recommendations and in the programming of the vaccination of vulnerable populations such as patients with CRDs. Organizational and educational strategies might prove useful to increase vaccine uptake by CRD patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0300-2896
1579-2129
1579-2129
DOI:10.1016/j.arbres.2024.05.026